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Calcium channelsSenescence is one of the primary responses to the activation of oncoproteins or down-regulation of tumor
suppressors in normal cells and is therefore considered as being anti-tumorigenic but the mechanisms
controlling this process are still much unknown. Calcium (Ca2+) plays a major role in many cellular processes
and calcium channels control many of the “hallmarks of cancer” but their involvement in tumor initiation is
poorly understood and remains unclear.
Therefore, in this article we review some striking senescence-associated characteristics and their potential
regulation by Ca2+. The main aim is to produce plausible hypothesis on how calcium homeostasis may
participate in cancer-related senescence. This article is part of a Special Issue entitled: 13th European Symposium
on Calcium.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Cell division is an essential tool used by multicellular organisms to
survive and, where necessary, to renew or repair damaged tissues.
However, genomes are continually damaged by environmental and
oxidative stresses and, in dividing cells, by errors in DNA replication
and mitosis. In fact, dividing cells can sometimes undergo genomic
mutations that, if occurring in cell cycle-controlling genes, put the
organism at risk to develop cancer [1]. To counteract this phenomenon,
complex organisms have developed some mechanisms in the attempt
to repair the damage, if possible, or to block proliferation in cells suscep-
tible of oncogenic transformation. The most common way for cells to
limit uncontrolled proliferation is to die by apoptosis (or programmed
cell death), but cells have developed alternative mechanisms to block
proliferation avoiding death.
The concept of cellular senescence was formally postulated ﬁve de-
cades ago when Hayﬂick and colleagues showed that normal cells had
a limited ability to proliferate in culture [2]. Further experiments demon-
strated that the loss of the proliferative potential was due to the telomere
shortening. Indeed, when the length of one ormore telomeres falls below
a certain threshold, the exposed DNA end is recognized as a DNA
doublestrand break by the DNA damage responsemachinery and triggers
the canonical DNA damage checkpoint. As a general mechanism, DNA
damage signals contribute to the activation of the p53 and pRB tumor
suppressor pathways, key regulators ofmuch of the senescence program.opean Symposium on Calcium.
y, Inserm U1003, Université de
9655 Villeneuve d'Ascq, France.Activation of p53 contributes to senescence-associated proliferation
arrest through one of its target genes, CDKN1a, encoding the cyclin/cdk
inhibitor p21CIP1. By inhibiting cyclin/cdk2 or cyclin/cdk4 complexes,
p21CIP1 activates the pRB tumor suppressor pathway, which inhibits
cell proliferation through numerous downstream targets, including the
E2F family of transcription factors, whose response genes are necessary
for progression through S phase [3,4]. Senescent cells are characterized
by speciﬁc features such as irreversible proliferation arrest, resistance
to apoptotic cell death and altered differentiated functions, such as mor-
phological modiﬁcations, changes in gene expression and production of
secreted proteins like metalloproteases, inﬂammatory cytokines and
growth factors. In the context of cancer, senescence would represent
an obstacle to overcome for the cells to become fully tumorigenic in
that it irreversibly arrests cell growth. As a matter of fact, cells with cel-
lular and molecular characteristics of senescence are found in benign
precancerous neoplasms associated with oncogene activation in both
humans and mice. For example, human nevi or moles are benign clonal
neoplasms containing melanocytes made senescent by a mutated Ras
or B-Raf [5]. Evidence for the tumor suppressor role of senescence has
been obtained also with mouse models of cancer triggered by ablation
of the tumor suppressor Pten in the prostate [6] or oncogenic N-Ras
expression in the hematopoietic system [7], in which the oncogenic ini-
tiating event led to the development of senescent premalignant lesions
with little evidence of apoptosis. However, even if cells attempts to
block uncontrolled proliferation by triggering senescence, cancer still
occurs. Many evidence indicate that at one point, some cells lose the
senescent phenotype and re-enter in the cell cycle progression, the so-
called senescence escape. It is thus not surprising that themain effectors
of senescence, such as p53 and pRB, are the most commonly lost func-
tions in mammalian cancers. Indeed, in experimental models of cancer,
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when the oncogenic event is combined with simultaneous deletion of
mediators of the senescence response [6,8]. Calcium controls many
aspects of the cellular lifecycle and it is conceivable that senescent cells
are characterized by a speciﬁc calcium signature that could be responsi-
ble in part for the senescent “phenotype”. Moreover, since the prominent
role of Ca2+ in cancer progression [9], particular perturbations of Ca2+
equilibrium could allow cells to bypass the proliferation arrest and be-
come tumorigenic.
Therefore, the aim of this review is to provide new hypothesis on
how Ca2+ signaling could participate in senescence during tumor initi-
ation. However, since on the one hand senescence is the tight cellular
balance between proliferation, apoptosis and autophagy and on the
other hand Ca2+ is a key controller of all these processes, we will reca-
pitulate ﬁrst the current knowledge of how it governs the “cellular life”.
2. Ca2+ and the regulation of the cellular fates
2.1. Proliferation
Typically quiescent cells exhibit localized short-term Ca2+ ﬂuctua-
tions, which represent native Ca2+ signaling pathways, required to
maintain basic cellular physiological activity. This “versatility” mostly
depends on spatial and temporal localization of Ca2+ in the so-called
nanodomains that activate speciﬁc pathways in speciﬁc circumstances.
Ca2+ transients have been detected in different parts of the cell
cycle. For example, anaphase in mammalian ﬁbroblasts and epithelial
cells is manifested through sustained Ca2+ elevation [10,11]. Ca2+ mo-
bilization have also been detected during the cell cycle, in cultured cells
and early embryos, taking cells out of G0 into G1, regulating events dur-
ing G1 and G2, and taking cells out of prophase into mitosis [10]. These
mitotic and other cell cycle events, including gene activation, have also
been shown to occur after Ca2+ injections into eggs or by using Ca2+
ionophores, whereas blocking such cytosolic Ca2+ increase has led to
mitosis prevention [12]. From these considerations, it is suggested that
sustained rise in cytosolic Ca2+ is important for the activation of quies-
cent cells and for speeding up one or more phases in cell cycle.
In cancer cells, the enhanced proliferation is usually associated with
increased cytosolic Ca2+ concentration [13]. Indeed, multiple transcrip-
tion factors responsible for cell cycle propagation highly depend on
Ca2+ ions. Among themost common regulators of those are calmodulin,
Ca2+/calmodulin-dependent protein kinases, calcineurin and protein
kinase C (PKC) [14].
For instance, Nuclear Factor of Activated T-cells (NFAT) signaling
pathway has been implemented inmultiple features of cellular cycle, in-
cluding proliferation. As a general mechanism, following phospholipase
Cγ (PLCγ) activation the phosphatidyl-inositol-1,4,5-trisphosphate
(InsP3) is produced and binds to the InsP3 receptor (InsP3R) on the en-
doplasmic reticulum (ER) membrane, inducing the efﬂux of Ca2+. Stro-
mal interaction molecule 1 (STIM1) and STIM2 subsequently detect the
decrease of ER Ca2+ stores, form small clusters and communicate with
the Orai channel protein at the plasma membrane to trigger Store-
Operated Calcium Entry (SOCE). Ca2+ binds to the Ca2+ sensor protein
calmodulin, resulting in activation of calcineurin, which assists in de-
phosphorylation of NFAT, its nuclear localization and subsequent target
genes expression. Interestingly, it has been recently shown that Orai1
detects local Ca2+ by N-terminal domain in speciﬁc nanodomains thus
effectively coupling Ca2+ entry to NFAT activation explaining such se-
lective activation of a fundamental downstream response by Orai1
[15]. Nevertheless, there is evidence that the same proliferation-
promoting Ca2+/calmodulin/calcineurin/NFAT pathway can be also ac-
tivated by the store-independent Ca2+ entry (e.g. through transient re-
ceptor potential (TRP) channels, Orai heteromers) [16–18].
Another ubiquitous regulator of genes that control cell proliferation
and survival is Nuclear Factor Kappa-light-chain-enhancer of activated
B cells (NF-κB). It has been shown to be constitutively activated insome types of cancer cell and can control the expression of genes that
are involved in the stimulation of cell proliferation, inhibition of apopto-
sis and increase of metastatic and angiogenic potential [19]. Ca2+ seems
to play a crucial role in the activity of NF-kB: using primary cultures of
neonatal cerebellar granule neurons, Lilienbaum and Israël found that
the opening of Ca2+ channels at the plasma membrane and at intracel-
lular stores is indispensable for the basal NF-κB activity [20]. They-
demonstrated that calmodulin, protein kinases C (PKCs), and the
p21 CIP1/Ras/phosphatidylinositol 3-kinase (PI3K)/Akt pathways are
simultaneously involved in the steps linking the Ca2+ signal to NF-κB
activity. Of note, there are studies that found NFAT and NF-κB transcrip-
tion factors or their upstream activators acting as tumor suppressors
and hence inhibit cellular proliferative rate [19,21]. Therefore, Ca2+-
dependent signaling pathways realized through NFAT and NF-κB
provide a peculiar tool for balancing between proliferation and cell
cycle arrest (Fig. 1; point 2.1).
2.2. Apoptosis
The involvement of Ca2+ and Ca2+ channels in extrinsic and intrinsic
apoptosis is a widely investigated topic (for review, see [22]). Both
during extrinsic and intrinsic apoptosis induction, the mitochondria
eventually become overloaded with Ca2+, causingmitochondrial depo-
larization and the mitochondrial outer membrane permeabilization
with the opening of the mitochondrial permeability transition pore
(mPTP) and the Voltage-Dependent Anion Channel (VDAC). This leads
to the release of the cytochrome C in the cytosol, allowing apoptosome
formation and the well-described caspase cascade.
The paradigm of apoptosis regulation by calcium resides in B-cell
lymphoma-2 (Bcl-2) activity. First, Bcl-2 ensures a balance between
Bcl-2 pro-apoptotic family members at the mitochondrion for the
BAK/BAX (Bcl-2 homologous antagonist killer/Bcl-2 associated X protein)
pore formation [23]. Additionally, these Bcl-2 protein members were
proposed to affect different Ca2+-handling proteins at the ER (inactiva-
tion of Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA), interaction
with the Inositol 1,4,5-Trisphosphate Receptor (IP3R)), leading to Ca2+
release from the ER, mitochondrial calcium uptake and cytosolic calcium
elevation.
Of note, increased levels of IP3R are usually associated with promo-
tion of cell death,whereas reduction of SERCA levels is a common feature
of cancer cells that avoid apoptosis [24,25]. Overall, Ca2+ movement
mechanism from the ER to the mitochondrion seems to be complex,
and elucidation of molecular complexes located in ER/mitochondrion
juxtaposition contacts is of primordial interest. In parallel, intracellular
Ca2+ elevation causes calcineurin-dependent dephosphorylation and ac-
tivation of Bcl-2 associated death promoter (Bad), a pro-apoptotic Bcl-2
familymember, as well as the activation of the Ca2+-dependent cysteine
protease calpain. This lattermediates the cleavage of severalmembers of
Bcl-2 family and activates caspase-12, promoting apoptotic cell death
induced by oxygen and glucose deprivation [26].
A recent study conducted in neuronal cells highlights the participa-
tion of the Ca2+ sensor Downstream Regulatory Element Antagonist
Modulator/potassium channel interacting protein (DREAM/KChIP)-3
in the apoptosis regulation. Besides its transcriptional repressor activi-
ty [27], DREAM/KChIP was demonstrated to bind to the mitochondrial
protein hexokinase I (HKI) and consequently could prevent apoptosis
by modulating VDAC conductance and cytochrome C release [28]
(Fig. 1, 2.2).
2.3. Autophagy
Autophagy is a self-digestive process that provides breakdown and
recycling of damaged or unused cellular components. In this way the
cell preserves its energy levels and at the same time provides additional
self-repairing mechanism. Hence, increased autophagy might be trig-
gered by various stress-factors, such as rise in free cytosolic Ca2+.
Fig. 1. Senescence may be regulated through different Ca2+-signaling mechanisms provided via several pathways: 2.1 — Transcription factors, including NFAT and NF-κB pathways, for
balancing between proliferation and cell cycle arrest; 2.2 — Regulation of apoptotic pathways; 2.3 — Regulation of autophagy; 3.1 — Regulatory changes in cell volume; 3.2 — Changes
in membrane potential due to remodeling of voltage-dependent channels; 3.3 — Altered telomerase activity; 3.4 — Subcellular localization of Ca2+-permeable channels, and their
mitochondria–endoplasmic reticulum associations in particular; 3.5— Transcriptional reprogramming; 3.6— SASP; 3.7— Increased autophagy. Numbers refer to the sections in the text.
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been demonstrated to both stimulate and prevent autophagy [29].
Interestingly, most studies report ER-residing IP3R as a prominent
inhibitor of autophagy [30]. However, in starvation-induced autophagy
IP3R has also been demonstrated as a stimulator [31]. There is some
evidence on the involvement of TRPV1 and L-type calcium channels in
autophagy regulation [32,33]. However, their direct implication is fur-
ther to be conﬁrmed by using more speciﬁc effectors. Interestingly,
autophagolysosome formation is much facilitated due to luminal Ca2+
release performed via TRPML1, also known as mucolipin-1. Moreover,
expressions of TRPML3 also localized in endo-lysosome compartments,
directly correlate with autophagy induction [34].
Channels expressed in themitochondria have been also demonstrat-
ed to regulate autophagy. Among them are Mitochondrial Calcium
Uniporter (MCU) and its regulator MCUR1, proteins responsible for mi-
tochondrial Ca2+ uptake, which have been shown to induce autophagy
when in downregulated state [35].3. Ca2+ and the senescent phenotype
3.1. Increase of cell volume
Modiﬁcation of the cell volume is one of the most prominent fea-
tures of senescent cells. In many cells, the volume increase is rapidly
counteracted by the so-called regulatory volume decrease (RVD) as a
consequence of Ca2+ entry through nonselective cation channels and
extrusion of ions like K+ and Cl− followed by water [36].
A possible participant in RVD is the non-selective cation channel
Transient Receptor Potential Vanilloid 4 (TRPV4), amember of the Tran-
sient Receptor Potential (TRP) superfamily that has been shown to react
to hypotonic stimuli with a conductance for Ca2+. Indeed, cells lacking
TRPV4 are not able to undergo RVD, a property that is re-established
in TRPV4-transfected cells [37].
The authors proposed that membrane stretching due to volume in-
crease can activate TRPV4. In consequence, TRPV4 mediates the inﬂux
of Ca2+ from the extracellular space, leading to the activation of intra-
cellular signaling cascades responsible for the regulation of RVD.In addition to TRPV4, TRPM7 is also proposed to be activated by os-
motic swelling and its knockdown attenuates RVD [38]. Piezo proteins
have recently been identiﬁed as nonselective cation channelsmediating
mechanosensory transduction in mammalian cells. A recent paper shed
new light on the role of Piezo-1 in the regulation and maintenance of
cell volumehomeostasis, in that its knockdown leads to zebraﬁsh eryth-
rocyte swelling [39].
In addition, inhibition of Ca2+/calmodulin-dependent kinases has
been shown to inhibit RVD or activation of cell volume regulatory ion
channels [40], and it has been concluded that calmodulin/Ca2+ com-
plexes are important for activation of RVD.
In senescent cells, this control mechanism is apparently modiﬁed
because after senescence stimulus, cells increase their volume that re-
mains unchanged with time. It is thus conceivable that senescent cells
regulate differentially calcium-permeable channels and the associated
downstream signaling pathways to trigger and maintain the speciﬁc
morphological features (Fig. 1, 3.1).
3.2. Changes in membrane potential
Membrane potential (Vm), is the voltage across the plasma mem-
brane provided due to differences in ion (e.g. Na+, K+, Ca2+)
concentrations between extra- and intra-cellular regions. Accordingly,
activity of ion permeable channels/transporters provokes changes
in Vm. Typically, in excitable cells, changes in Vm are required for prop-
agation of action potential, driving force of cell-to-cell communication,
whereas in other types of cells, Vm is a biophysical activator of intracel-
lular signaling. Indeed, Vm has been shown to play key roles in multiple
cellular activities such as proliferation and differentiation [9]. Recently,
Lallet-Daher and colleagues have suggested the association of Vm with
another feature of cellular physiology in senescence [41]. They have
demonstrated that oncogenic stress triggers an increase of potassium
channel KCNA1 expression and its relocation from the cytoplasm to
the membrane responsible for changes in Vm and leading to cellular
senescence. In similar manner, Ca2+ channels have been known to
modulate Vm, however no direct evidence on their involvement in
senescence initiation is yet known. In addition, Vm regulates activity
of voltage-gated channels that provide another signiﬁcant trail of
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less, this aspect has not been investigated in the work of Lallet-Daher.
Therefore, since changes in Vm have been implemented in oncogene-
induced senescence, it would be reasonable to investigatewhether sim-
ilar effects could be potentiated by remodeling of Ca2+-channels as
wells as could affect downstream Ca2+-signaling (Fig. 1, 3.2).
3.3. Inhibition of telomerase activity
Expression of telomerase is themost commonmechanism bywhich
cancer cells stabilize their telomeres and hence avoid replicative senes-
cence [43]. Telomerase activity can be modulated by Ca2+ homeostasis.
In HaCaT human epidermal keratinocytes, the levels of telomerase
activity were reduced in response to ER Ca2+ release even without
the downregulation of the human Telomerase Reverse Transcriptase
(hTERT) expression, suggesting that Ca2+ release can directly modulate
the activity of the telomerase complex [44]. Thismodulationwas postu-
lated to occur via the S100A8 Ca2+-binding protein, which inhibits the
telomerase complex (Fig. 1, 3.2). Ca2+ can also exert the opposite effect,
in that elevated extracellular Ca2+ levels can enhance telomerase activ-
ity likely by L-type voltage-operated Ca2+ channels [45].
3.4. Mitochondria–endoplasmic reticulum interactions
The mitochondria and ER are well-recognized nodes where signiﬁ-
cant remodeling of Ca2+ signaling occurs in cancer cells to sustain pro-
liferation and avoid cell death [46]. In a recent study conducted with a
loss of function approach, ER-to-mitochondria Ca2+ transmission is
proposed as a potent senescence-inducing signal. Indeed, senescent
cells exhibit an altered calcium homeostasis. During oncogene and rep-
licative senescence induction, the Inositol 1,4,5-Trisphosphate Receptor,
Type 2 (ITPR2) triggers calcium release from the ER followed by mito-
chondrial calcium accumulation through the MCU channel. This Ca2+
remodeling causes a drop in mitochondrial membrane potential and
an accumulation of oxygen species [47]. Knockdown of MCU or MICU1
modulator prior to oncogenic stress application leads to a strong de-
crease inmitochondrial accumulation correlated to loss ofmitochondri-
al depolarization and senescence escape. Although the precise
mechanismunderlying ER-to-mitochondria Ca2+ transfer during senes-
cence is still unclear, it is tempting to speculate a link between mito-
chondrial Ca2+ modulation, mitochondrial respiration and eventually
metabolic crisis such as autophagy [22,48] (Fig. 1, 3.4). Mitochondria
and ER networks are interconnected in punctuate microdomains called
the Mitochondria–Associated Endoplasmic Reticulum Membrane
(MAM) sharing structural and functional interactions essential for
Ca2+ signaling, lipid transport, energy metabolism, and cell death
[49]. In mammals, these MAMs are composed of VDAC located at the
outer mitochondrial membrane interacting with the IP3R at the ER
membrane through themolecular chaperone glucose-regulated protein
75 (Grp75), allowing Ca2+ transfer from the ER to themitochondria [50]
(Fig. 1, 3.4). These ‘hotspots’ of calcium transfer are now considered as
crosstalk platforms in response to various stresses associated with spe-
ciﬁc protein recruitment. Altogether, it appears that Ca2+ signals regu-
lating cell death, autophagy and metabolism depend on spatially and
dynamically restricted domains. Under this perspective, the subcellular
localization of all calcium permeable channels appears to be of great
signiﬁcance.
3.5. Transcriptional reprogramming
In Section 2.1 we reported some of the potential effects of Ca2+ in
the regulation of transcription factors responsible for cell proliferation.
As a key regulator of senescence, p53 is the ﬁrst that should be taken
into account. A direct link between Ca2+ and p53 activity was provided
by Lu et al., showing that siRNA-mediated silencing of Cav3.1 channels
expressed in certain esophageal carcinoma cell lines can reduce cellproliferation via the p53 tumor-suppressing transcription factor-
dependent pathway, leading to the upregulation of cell-cycle arrest pro-
tein p21CIP1 [51].Moreover, calcium can indirectlymodulate the expres-
sion and function of p53 by regulating the activity of the large
conductance Ca2+-dependent K+ channel (BKCa). Indeed, the pharma-
cological blockade of BKCa channels in human HeLa cervical and A2780
ovarian cancer cell lines has been reported to induce the increased ex-
pression of p53 and cell-cycle arrest in the G1 phase [52], suggesting
that BKCa channel activity is required to keep p53 under negative con-
trol to prevent its antitumor actions. Additionally, Ca2+ can regulate
the ability of partner proteins to bind and modulate p53 activity.
Mueller and colleagues have in fact demonstrated that the S100A2, a
member of the subfamily of S100 Ca2+-binding proteins, is able to inter-
act with p53 in a Ca2+-dependent manner, and that this interaction fa-
cilitates binding of p53 to its responsive element [53]. By contrast, the
S100B Ca2+-binding protein exerts the opposite role, by decreasing
p53 DNA binding and transcriptional activity [54]. Moreover, Delphin
et al. demonstrated that in vitro, Ca2+-dependent PKC is able to phos-
phorylate recombinant murine p53 protein on several residues
contained within a conserved basic region of 25 amino acids, located
in the C-terminal part of the protein, thus increasing the stability of
p53 protein tetramers and oligomers [55].
Ca2+ is the major regulator of NFAT, however no data are available
on its role in cancer-related senescence. However, dysregulation of
NFAT is now known to be associated with malignant transformation
and the development of cancer. For example, it is expressed and tran-
scriptionally active in human metastatic melanoma cell lines, in which
it is activated by oncogenic B-RafV600E via the canonical MEK/ERK path-
way [56]. Moreover, this speciﬁc pathway is also known to induce
senescent-like cycle arrest of human naevi, suggesting that the addi-
tional NFAT activation is required for cells to become tumorigenic. As
a matter of fact, recently Umemura and colleagues [57] showed that
STIM1 and Orai1 are expressed in metastatic human melanoma cell
lines, while the melanocyte cell line, HEMA-LP, displayed only a low
level of Orai1 expression that could explain partially the increased acti-
vation of NFAT in malignant cells. It is thus conceivable that the activa-
tion of NFAT occurs in part as the result of changes in Ca2+ homeostasis
due to channels expression and function remodeling that can occur in
cells during the tumorigenic process, allowing cells to pass from a
senescent-like to a more aggressive phenotype.
Little is known about the role of NF-κB cancer-associated
senescence. It has been shown that chronic NF-κB activation delays
H-RasV12-induced premature senescence in IMR-90 normal human dip-
loid ﬁbroblasts [58]. Accordingly, inhibition of p53 or p65 expression
alone had no overt effect on the growth arrest phenotype induced by
oncogenic H-RasV12 in IMR-90 cells, but inhibiting both p53 and p65 si-
multaneously promoted cell growth and reversed the senescent pheno-
type [59]. In the same paper, the authors found that NF-κB acts as a
master regulator of the Senescence-associated secretory phenotype
(SASP), inﬂuencing the expression of several genes, including interleu-
kin 6 (IL-6), IL-8, CXCL1 chemokine, InterCellular Adhesion Molecule
1(ICAM1), matrix metalloproteinases and noninﬂammatory response
genes. Indeed, oncogene-induced senescence has been associated with
secretion of multiple CXCR2-binding chemokines in NF-κB-dependent
manner [60] (Fig. 1, 3.5).
3.6. Senescence-associated secretory phenotype (SASP)
It is well known that senescent cells are able to secrete a large num-
ber of soluble factors (the so-called SASP) like growth factors, cytokines,
extracellularmatrix, and degradative enzymes, all of which can alter tis-
sue microenvironments and affect nearby epithelial cells [61–63].
Calcium channels are well known regulators of secretion. Indeed,
Cav3.2 T-type calcium channels were found to be involved in calcium-
dependent secretion of neuroendocrine prostate cancer cells probably
by stimulating intracellular trafﬁcking and exocytosis [64]. Moreover,
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hanced secretion of angiogenic factors and TRPM8 is in part responsible
for the secretion ofmitogenic factors in prostate cancer cells [9]. Indeed,
modulation of the expression of calcium channels in senescent cells
could contribute to regulate the secretory phenotype acting either
directly on the exocytic pathway or indirectly by promoting the activity
of transcription factors such as NF-κB (Fig. 1, 3.6).3.7. Autophagic ﬂux
Autophagy has been linked with aging and indeed found in senes-
cence transition phase (reviewed in [65]). Actually, the signiﬁcant switch
of protein degradation from proteosomal into autophagosomal pathway
has been reported to take place during senescence [66]. Indeed, autoph-
agy has been suggested to mediate acquisition of oncogene-induced
senescence, whereas its inhibition delays senescence-associated pro-
cesses, including speciﬁc secretion phenotype [67]. In fact, the main re-
sult of autophagy functioning is the production of particular vesicles
that assist in the degradation of a required material after their fusion
with lysosomes. Indeed, previously it has been shown that lysosomal
membrane permeabilization induces autophagy and triggers stress-
induced premature senescence, which is reversible by autophagy inhibi-
tion [68]. In fact, one of the most spread assays for determination of
senescent cells is enhanced lysosomal enzyme β-galactosidase activity.
In consistence with this, during Ras-induced-senescence the kinetics of
β-galactosidase activity and autophagy activation have been tightly
correlated [67].
Indeed, the evidence of a profound relationship between the au-
tophagy process and oncogene-induced senescence strengthens the po-
tential role of Ca2+ signaling as one of themain actors in the acquisition
of the senescent phenotype (Fig. 1, 3.7).4. Concluding remarks
Senescence is a critical step through which “oncogene-stressed”
cells pass to limit the proliferation, the consequent accumulation of
genomic mutations and ﬁnally the tumor progression.
Over these last few years, the importance of Ca2+ channels in regu-
lating fewhallmarks of cancer is emerging. Indeed, they have been dem-
onstrated to play important roles in 1) self-sufﬁciency in growth signals
and aberrant cell proliferation, 2) insensitivity to antigrowth signals,
3) evasion of programmed cell death (apoptosis), and 4) tissue invasion
andmetastasis. Some of these channels have a speciﬁc proﬁle of expres-
sion depending on the cancer cell phenotype thereby pointing on the
possibility to use them as diagnostic/prognostic markers for cancer
development.
Proliferating tumor cells show very distinct patterns of expression
and function of Ca2+ channels if compared to their normal counterparts.
It is therefore highly probable that some of the features of this “interme-
diate” phenotype are regulated by Ca2+ homeostasis, through the
modulation of ion ﬂuxes caused by differential expression and/or re-
modeling of channels activities. However, senescence is often bypassed
and cells re-acquire features of proliferating cells allowing cancer to
arise and progress but little is known about the molecular mechanisms
involved in this phenomenon. Thus, unveiling their role in senescence
could be of help for the development of newmore conscious therapeu-
tic strategies targeting Ca2+ channels, or to identify new early diagnos-
tic markers.Transparency document
The Transparency document associated with this article can be
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